CoChat

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome

Spranger, Joachim, Möhlig, Matthias, Wegewitz, Uta, Ristow, Michael, Pfeiffer, Andreas F. H., Schill, Thilo, Schlösser, Hans W., Brabant, Georg, Schöfl, Christof · 2004 · Clinical Endocrinology
Cited by 128

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Summary: objective The polycystic ovary syndrome (PCOS) is associated with obesity and insulin resistance predisposing to diabetes mellitus type 2 and atherosclerosis. Adiponectin is a recently discovered adipocytokine with insulin‐sensitizing and putative antiatherosclerotic properties. The aim of the study was to elucidate determinants of circulating adiponectin levels and to investigate the potential role of adiponectin in insulin resistance in PCOS women. patients and measurements Plasma adiponectin and parameters of obesity, insulin resistance and hyperandrogenism were measured In 62 women with PCOS and in 35 healthy female controls. results Both in PCOS and controls, adiponectin levels were lower in overweight or obese women than in normal‐weight women, without any difference between PCOS and controls after adjustment for body mass index (BMI). In PCOS and in controls there was a significant correlation of adiponectin with BMI (r = −0·516, P < 0·001), fasting insulin (r = −0·404, P < 0·001), homeostasis model sensitivity (HOMA %S) (r = −0·424, P < 0·001) and testosterone (r = −0·279, P < 0·01), but no correlation with androstenedione (r = −0·112, P = 0·325), 17‐OH‐progesterone (r =−0·031, P = 0·784) or the LH/FSH ratio (r =−0·033, P = 0·753). Multiple linear regression analysis revealed that BMI and HOMA %S but not testosterone were independently associated with adiponectin plasma levels, explaining 16% (BMI) and 13% (HOMA %S) of the variability of adiponectin, respectively. In PCOS patients insulin sensitivity, as indicated by continuous infusion of glucose with model assessment (CIGMA %S) was significantly correlated with adiponectin (r = 0·55; P < 0·001), BMI (r =−0·575; P < 0·001), waist‐to‐hip ratio (WHR) (r =−0·48; P = 0·001), body fat mass assessed by dual‐energy X‐ray‐absorptiometry (DEXA) [Dexa‐fat (total) (r = −0·61; P < 0·001) and Dexa‐fat (trunk) (r = −0·59; P < 0·001)] and with testosterone (r = −0·42; P = 0·001). Multiple linear regression analysis demonstrated that markers of obesity such as BMI, total or truncal fat mass, age and adiponectin were independently associated with CIGMA %S, and that circulating adiponectin accounted for about 18% of the degree of insulin resistance in PCOS. By contrast, testosterone was not a significant factor, suggesting that PCOS per se did not affect insulin sensitivity independent from obesity, age and adiponectin. Metformin treatment for 6 months in insulin‐resistant PCOS women (n = 9) had no effect on plasma adiponectin (P = 0·59) despite significant loss of weight and fat mass and improvement in hyperandrogenaemia. conclusions PCOS per se is not associated with decreased levels of plasma adiponectin. However, circulating adiponectin is independently associated with the degree of insulin resistance in PCOS women and may contribute to the development and/or maintenance of insulin resistance independent from adiposity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2004.02159.x

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 128

Metadata

Authors
Spranger, J., Möhlig, M., Wegewitz, U., Ristow, M., Pfeiffer, A. F. H., Schill, T., Schlösser, H. W., Brabant, G., & Schöfl, C.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2004-11-02
Volume
61
Issue
6
Pages
738-746
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2137194800
Cited by
128
References
14
FWCI
8.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. https://app.cochat.ai/papers/10.1111/j.1365-2265.2004.02159.x
The paper
Spranger, J., Möhlig, M., Wegewitz, U., Ristow, M., Pfeiffer, A. F. H., Schill, T., Schlösser, H. W., Brabant, G., & Schöfl, C. (2004). Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2004.02159.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.